Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.
Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Methods Mol Biol. 2021;2292:3-15. doi: 10.1007/978-1-0716-1354-2_1.
Recent reports suggest that urine is a useful noninvasive tool for the identification of urogenital tumors, including bladder, prostate, kidney, and other nonurological cancers. As a liquid biopsy, urine represents an important source for the improvement of new promising biomarkers, a suitable tool to identify indolent cancer and avoid overtreatment. Urine is enriched with DNAs, RNAs, proteins, circulating tumor cells, exosomes, and other small molecules which can be detected with several diagnostic methodologies.We provide an overview of the ongoing state of urinary biomarkers underlying both their potential utilities to improve cancer prognosis, diagnosis, and therapeutic strategy and their limitations.
最近的报告表明,尿液是一种有用的非侵入性工具,可用于识别泌尿系统肿瘤,包括膀胱癌、前列腺癌、肾癌和其他非泌尿系统癌症。作为一种液体活检,尿液是改善新的有前途的生物标志物的重要来源,是识别惰性癌症和避免过度治疗的合适工具。尿液中富含 DNA、RNA、蛋白质、循环肿瘤细胞、外泌体和其他小分子,可以通过几种诊断方法检测到。我们概述了尿液生物标志物的现状,包括它们在改善癌症预后、诊断和治疗策略方面的潜在用途及其局限性。